< Terug naar vorige pagina
Onderzoeker
Camila Esguerra
- Disciplines:Ontdekking en evaluatie van biomarkers, Ontdekking en evaluatie van geneesmiddelen, Medicinale producten, Farmaceutica, Farmacognosie en fytochemie, Farmacologie, Farmacotherapie, Toxicologie en toxinologie, Andere farmaceutische wetenschappen
Affiliaties
- Moleculaire Bio-ontdekking (Afdeling)
Lid
Vanaf1 apr 2013 → 30 nov 2014
Projecten
1 - 5 of 5
- Nieuwe behandeling van cystinosis.Vanaf1 mrt 2015 → 28 feb 2020Financiering: FWO Onderzoeksproject (incl. WEAVE projecten)
- Establishment of zebrafish model of attention-deficit/hyperactivity disorderVanaf1 dec 2010 → 15 jul 2016Financiering: IWT persoonsgebonden financ. - strategische onderzoeksbeurzen
- Functionele analyse van nieuwe, laag-moleculaire-massa modulatoren van BMP en Wnt signaalpaden in zebravis.Vanaf1 jan 2010 → 31 dec 2013Financiering: FWO Onderzoeksproject (incl. WEAVE projecten)
- Functionele genomics-studie in zebravis over de rol van schildklierhormonen en dejodasen in de vroege embryonale ontwikkeling.Vanaf1 jan 2010 → 31 dec 2013Financiering: FWO Onderzoeksproject
- Kennisplatform functionele peptidomics.Vanaf1 okt 2009 → 30 sep 2013Financiering: IOF - Industrieel Onderzoeksfonds
Publicaties
1 - 10 van 37
- Seizing the moment: Zebrafish epilepsy models(2020)
Auteurs: Camila Esguerra
Pagina's: 1 - 20 - New insights into the early mechanisms of epileptogenesis in a zebrafish model of Dravet syndrome(2020)
Auteurs: Camila Esguerra
Pagina's: 549 - 560 - Zebrafish-Based Discovery of Antiseizure Compounds from the North Sea: Isoquinoline Alkaloids TMC-120A and TMC-120B(2019)
Auteurs: Daniëlle Copmans, Michèle Partoens, Camila Esguerra, Peter de Witte
- Identification of GSK-3 as a Potential Therapeutic Entry Point for Epilepsy(2019)
Auteurs: Camila Esguerra, Fred Van Leuven, Peter de Witte
Pagina's: 1992 - 2003 - Are zebrafish larvae suitable for assessing the hepatotoxicity potential of drug candidates?(2015)
Auteurs: Natalie Mesens, Rik Nuyts, Peter de Witte, Camila Esguerra
Pagina's: 1017 - 29 - CHD2 variants are a risk factor for photosensitivity in epilepsy(2015)
Auteurs: Camila Esguerra
Pagina's: 1198 - 1207 - Deiodinase knockdown during early zebrafish development affects growth, development, energy metabolism, motility and phototransduction(2015)
Auteurs: Marjolein Heijlen, Anne Houbrechts, Camila Esguerra, Veerle Darras
Pagina's: 1 - 22 - Cross-species pharmacological characterization of the allylglycine seizure model in mice and larval zebrafish(2015)
Auteurs: Peter de Witte, Alex Crawford, Camila Esguerra
Pagina's: 53 - 63 - Pharmacological characterization of an antisense knockdown zebrafish model of dravet syndrome: inhibition of epileptic seizures by the serotonin agonist fenfluramine(2015)
Auteurs: Yifan Zhang, Daniëlle Copmans, Lieven Lagae, Peter de Witte, Camila Esguerra
- Smoc2 Modulates Embryonic Myelopoiesis During Zebrafish Development(2014)
Auteurs: Hendrik Mommaerts, Camila Esguerra, Frank Luyten, Przemko Tylzanowski
Pagina's: 1375 - 1390
Patenten
1 - 8 van 8
- Treatment of epilepsy (Inventor)
- Treatment of epilepsy with plinabulin or halimide or diketopiperazine derivatives (Inventor)
- Treatment of epilepsy with plinabulin or halimide or diketopiperazine derivatives (Inventor)
- Treatment of epilepsy (Inventor)
- Anticonvulsant activity of bisabolene sesquiterpenoids isolated from turmeric oil (Inventor)
- Anticonvulsant activity of turmeric oil and bisabolene sesquiterpenoids (Inventor)
- DAN SHEN EXTRACTS AND COMPOUNDS (Inventor)
- ANTICONVULSANT ACTIVITY OF GSK-3BETA INHIBITORS (Inventor)